Murae Organisor (BOM:542724) Debt-to-Equity : N/A (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Murae Organisor Debt-to-Equity?

Murae Organisor's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0.00 Mil. Murae Organisor's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0.00 Mil. Murae Organisor's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₹0.00 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Murae Organisor's Debt-to-Equity or its related term are showing as below:

BOM:542724' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.05 Med: 0.75 Max: 1.61
Current: 0.05

During the past 8 years, the highest Debt-to-Equity Ratio of Murae Organisor was 1.61. The lowest was 0.05. And the median was 0.75.

BOM:542724's Debt-to-Equity is ranked better than
81.34% of 852 companies
in the Drug Manufacturers industry
Industry Median: 0.29 vs BOM:542724: 0.05

Murae Organisor Debt-to-Equity Historical Data

The historical data trend for Murae Organisor's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Murae Organisor Debt-to-Equity Chart

Murae Organisor Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Debt-to-Equity

Get a 7-Day Free Trial

1.61

0.64

0.78

0.58

0.47

Murae Organisor Quarterly Data
	Mar18	Sep18	Dec18	Mar19	Sep19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															N/A	0.47	N/A	0.05	N/A

Competitive Comparison of Murae Organisor's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Murae Organisor's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Murae Organisor's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Murae Organisor's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Murae Organisor's Debt-to-Equity falls into.

Murae Organisor Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Murae Organisor's Debt to Equity Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(87.399	+	0)	/	187.065
	=	0.47

Murae Organisor's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	0
	=	N/A

Murae Organisor (BOM:542724) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Murae Organisor Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Murae Organisor's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Murae Organisor (BOM:542724) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Murae Organisor Ltd (BOM:542724) » Definitions » Debt-to-Equity

Traded in Other Exchanges

N/A

Address

Science City Road, A-1106, Empire Business Hub, Near Auda Water Tank, Sola, Ahmedabad, GJ, IND, 380060

Website

http://www.earumpharma.com

Murae Organisor Ltd Formerly Earum Pharmaceuticals Ltd is engaged in the pharmaceutical business. It is involved in the marketing, trading, and distribution of a wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, dermatology products, cerebral activator drugs, neurological drugs, steroids, gynecology drugs, calcium, multivitamins, antioxidants, and injections. It offers a wide range of pharmaceutical formulation products that are marketed under its brand name. Apart from pharmaceutical formulation products, the company also deals in the trading of active pharmaceutical ingredients.

Murae Organisor (BOM:542724) Headlines

No Headlines